NO20011967L - Propofolblandinger omfattende pentetrat - Google Patents

Propofolblandinger omfattende pentetrat

Info

Publication number
NO20011967L
NO20011967L NO20011967A NO20011967A NO20011967L NO 20011967 L NO20011967 L NO 20011967L NO 20011967 A NO20011967 A NO 20011967A NO 20011967 A NO20011967 A NO 20011967A NO 20011967 L NO20011967 L NO 20011967L
Authority
NO
Norway
Prior art keywords
propofol
pentetrate
mixtures
microorganisms
hours
Prior art date
Application number
NO20011967A
Other languages
English (en)
Norwegian (no)
Other versions
NO20011967D0 (no
Inventor
Mary Mathew George
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Publication of NO20011967D0 publication Critical patent/NO20011967D0/no
Publication of NO20011967L publication Critical patent/NO20011967L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Anesthesiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Epoxy Compounds (AREA)
  • Polyethers (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
NO20011967A 1998-10-22 2001-04-20 Propofolblandinger omfattende pentetrat NO20011967L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/176,881 US6028108A (en) 1998-10-22 1998-10-22 Propofol composition comprising pentetate
PCT/US1999/024906 WO2000023050A1 (en) 1998-10-22 1999-10-21 Propofol composition comprising pentetate

Publications (2)

Publication Number Publication Date
NO20011967D0 NO20011967D0 (no) 2001-04-20
NO20011967L true NO20011967L (no) 2001-05-09

Family

ID=22646263

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20011967A NO20011967L (no) 1998-10-22 2001-04-20 Propofolblandinger omfattende pentetrat

Country Status (17)

Country Link
US (1) US6028108A (ru)
EP (1) EP1124536B1 (ru)
JP (1) JP2002527465A (ru)
KR (1) KR20010080263A (ru)
CN (1) CN1331582A (ru)
AT (1) ATE290367T1 (ru)
AU (1) AU1226400A (ru)
BR (1) BR9914725A (ru)
CA (1) CA2347118A1 (ru)
CZ (1) CZ20011420A3 (ru)
DE (1) DE69924133D1 (ru)
EA (1) EA003771B1 (ru)
IL (1) IL142555A0 (ru)
NO (1) NO20011967L (ru)
NZ (1) NZ511149A (ru)
PL (1) PL347395A1 (ru)
WO (1) WO2000023050A1 (ru)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6749868B1 (en) 1993-02-22 2004-06-15 American Bioscience, Inc. Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
AU759641B2 (en) * 1998-08-19 2003-04-17 Skyepharma Canada Inc. Injectable aqueous dispersions of propofol
US6177477B1 (en) * 1999-03-24 2001-01-23 American Home Products Corporation Propofol formulation containing TRIS
EP1165046A1 (en) * 1999-04-05 2002-01-02 Baxter International Inc. Propofol compositions containing preservative additives
WO2001097779A2 (en) 2000-06-16 2001-12-27 Rtp Pharma Inc. Improved injectable dispersions of propofol
US20030054042A1 (en) * 2001-09-14 2003-03-20 Elaine Liversidge Stabilization of chemical compounds using nanoparticulate formulations
WO2004037750A2 (en) * 2002-01-25 2004-05-06 Theravance, Inc. Short-acting sedative hypnotic agents for anesthesia and sedation
US20080220075A1 (en) * 2002-03-20 2008-09-11 Elan Pharma International Ltd. Nanoparticulate compositions of angiogenesis inhibitors
AU2003230691A1 (en) * 2002-03-20 2003-10-08 Elan Pharma International Ltd. Nanoparticulate compositions of angiogenesis inhibitors
WO2003105817A1 (en) * 2002-05-02 2003-12-24 Fdl, Inc. Novel parenteral composition comprising propofol
CA2503956A1 (en) * 2002-10-29 2004-05-13 Transform Pharmaceuticals, Inc. Propofol with cysteine
LT1585548T (lt) * 2002-12-09 2018-09-25 Abraxis Bioscience, Llc Farmakologinių agentų kompozicijos ir įvedimo būdai
US20040225022A1 (en) * 2003-05-09 2004-11-11 Desai Neil P. Propofol formulation containing reduced oil and surfactants
US8476010B2 (en) 2003-07-10 2013-07-02 App Pharmaceuticals Llc Propofol formulations with non-reactive container closures
PT1648413E (pt) * 2003-07-23 2009-12-28 Theravance Inc Composições farmacêuticas de um agente hipnótico sedativo de acção curta
US8546453B2 (en) 2003-08-14 2013-10-01 Rensheng Zhang Propofol compositions and methods for reducing pain associated with propofol injection
CN101090736A (zh) * 2004-09-13 2007-12-19 印度血清及疫苗有限公司 具抗微生物的防腐效果的用于静脉给药的稳定乳剂组合物
US8557861B2 (en) * 2004-09-28 2013-10-15 Mast Therapeutics, Inc. Low oil emulsion compositions for delivering taxoids and other insoluble drugs
WO2007000662A2 (en) * 2005-02-03 2007-01-04 Taro Pharmaceuticals U.S.A., Inc. Novel propofol composition comprising ascorbic acid or pharmaceutically acceptable salts thereof
CN100358513C (zh) * 2005-04-07 2008-01-02 常州市第四制药厂有限公司 一种丙泊酚注射液的制备工艺
WO2006112276A1 (ja) * 2005-04-13 2006-10-26 Otsuka Pharmaceutical Factory, Inc. プロポフォール含有脂肪乳剤
US20090131538A1 (en) * 2005-05-27 2009-05-21 Taro Pharmaceuticals North America, Inc. c/o Taro Pharmaceuticals U.S.A., Inc. Novel propofol composition comprising a pharmaceutically acceptable salt of formaldehyde sulfoxylate
US20070031482A1 (en) * 2005-08-02 2007-02-08 Ceramoptec Industries, Ind. PDT treatment method for cellulites and cosmetic use
EA200800258A1 (ru) * 2005-08-05 2008-06-30 Бхарат Сирумс Энд Вэксинс Лтд. Эмульсионные композиции пропофола для внутривенного введения, имеющие консервирующую эффективность
EA014673B1 (ru) * 2005-08-12 2010-12-30 Бхарат Сирумс Энд Вэксинс Лтд. Водные анестезирующие композиции, содержащие пропофол
DK1931321T3 (en) * 2005-08-31 2019-04-15 Abraxis Bioscience Llc COMPOSITIONS CONTAINING VERY WATER-SOLUBLE PHARMACEUTICAL AND ANTIMICROBIAL AGENTS
CA2620389C (en) * 2005-08-31 2014-06-17 Abraxis Bioscience, Llc Compositions and methods for preparation of poorly water soluble drugs with increased stability
TWI376239B (en) * 2006-02-01 2012-11-11 Andrew Xian Chen Vitamin e succinate stabilized pharmaceutical compositions, methods for the preparation and the use thereof
WO2008023384A1 (en) * 2006-08-24 2008-02-28 Bharat Serums & Vaccines Ltd. Propofol emulsion compositions for intravenous administration
US9132090B2 (en) 2009-01-13 2015-09-15 Chetan Majmudar Propofol based anesthetic with preservative
WO2013172999A1 (en) 2012-05-16 2013-11-21 Mewa Singh Pharmaceutical compositions for the delivery of substantially water-insoluble drugs
EP2884964A4 (en) * 2012-08-16 2016-01-06 Emcure Pharmaceuticals Ltd PHARMACEUTICAL COMPOSITION OF PROPOFOL
EP3331567B1 (en) 2015-07-24 2020-09-23 Neon Laboratories Ltd. Stabilized injectable emulsion of propofol and ketamine
US11622937B2 (en) 2015-08-20 2023-04-11 Mewa Singh Polyphenolic polymer to make water-insoluble molecules become water-soluble

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4798846A (en) * 1974-03-28 1989-01-17 Imperial Chemical Industries Plc Pharmaceutical compositions
GB1472793A (en) * 1974-03-28 1977-05-04 Ici Ltd Pharmaceutical compositions
JPS61204137A (ja) * 1985-03-06 1986-09-10 Yutaka Mizushima 放射性造影剤
GB9405593D0 (en) * 1994-03-22 1994-05-11 Zeneca Ltd Pharmaceutical compositions
US5614170A (en) * 1994-11-30 1997-03-25 Hemagen/Pfc Paramagnetic complexes of N-alkyl-N-hydroxylamides of organic acids and emulsions containing same for magnetic resonance imaging (MRI)
JP2868206B2 (ja) * 1996-04-16 1999-03-10 株式会社オフテクス 消毒および／または防腐のための有害微生物防除用組成物

Also Published As

Publication number Publication date
KR20010080263A (ko) 2001-08-22
CN1331582A (zh) 2002-01-16
EP1124536A1 (en) 2001-08-22
BR9914725A (pt) 2001-08-07
NO20011967D0 (no) 2001-04-20
EA200100459A1 (ru) 2001-10-22
ATE290367T1 (de) 2005-03-15
WO2000023050A1 (en) 2000-04-27
AU1226400A (en) 2000-05-08
DE69924133D1 (de) 2005-04-14
CA2347118A1 (en) 2000-04-27
EA003771B1 (ru) 2003-08-28
PL347395A1 (en) 2002-04-08
CZ20011420A3 (cs) 2001-09-12
US6028108A (en) 2000-02-22
NZ511149A (en) 2003-10-31
JP2002527465A (ja) 2002-08-27
EP1124536B1 (en) 2005-03-09
IL142555A0 (en) 2002-03-10

Similar Documents

Publication Publication Date Title
NO20011967L (no) Propofolblandinger omfattende pentetrat
DK1163007T3 (da) TRIS-holdige propofol-formuleringer
CA2319810A1 (en) Propofol composition containing sulfite
EP1238677A3 (en) Parenteral fat emulsions comprising edetate as preservative
KR880004097A (ko) 글리코펩티드 항생물질
ATE226815T1 (de) Herstellung von arzneimitteln
MY125921A (en) Compositions containing organic compounds
DE68909139T2 (de) Substanz FR901228 und deren Herstellung.
DK0785948T3 (da) Analoger af keratinocyt vækstfaktor
ES2037742T3 (es) Procedimiento de obtencion de una composicion para administracion intravenosa.
FI891581A0 (fi) Peptidderivat.
DK99987D0 (da) Oestrogenpraeparater
ATE135703T1 (de) Substituierte 2-imidazoline und verfahren zur herstellung sowie deren verwendung
EP0820770A3 (de) Arzneimittel zur Behandlung von Neuropathien, das ein lipidlösliches Thiamin und ein Antioxidans enthält
DE69019848D1 (de) Substanzen WS 7622 A,B,C und D, deren Derivate, Verfahren zu deren Herstellung sowie deren Verwendung.
DE69929180D1 (de) Verfahren zur mikrobiellen umwandlung von phytosterolen in androstendion und androstadiendion
ES2059879T3 (es) Compuestos sn-198c fisiologicamente activos y metodo y bacterias para su produccion.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application